KYPROLIS Trademark

Trademark Overview

On Thursday, July 12, 2012, a trademark application was filed for KYPROLIS with the United States Patent and Trademark Office. The USPTO has given the KYPROLIS trademark a serial number of 85675722. The federal status of this trademark filing is ABANDONED - INCOMPLETE RESPONSE as of Monday, May 22, 2017. This trademark is owned by Onyx Pharmaceuticals, Inc.. The KYPROLIS trademark is filed in the Pharmaceutical Products category with the following description:

Human pharmaceuticals for use in the prevention and treatment of cancer, oncology, tumors, solid and hematological tumors and growths, hematological diseases and disorders
kyprolis

General Information

Serial Number85675722
Word MarkKYPROLIS
Filing DateThursday, July 12, 2012
Status600 - ABANDONED - INCOMPLETE RESPONSE
Status DateMonday, May 22, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 2, 2013

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of the stylized term "KYPROLIS" with a shaded triangle on the top right side of the "O". Below the "O" are two shaded bands of varying width and length that have both a rounded corner and one that comes to a point.
Goods and ServicesHuman pharmaceuticals for use in the prevention and treatment of cancer, oncology, tumors, solid and hematological tumors and growths, hematological diseases and disorders
Translation of Words in MarkThe wording "KYPROLIS" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 19, 2012
Primary Code005
First Use Anywhere DateMonday, July 30, 2012
First Use In Commerce DateMonday, July 30, 2012

Trademark Owner History

Party NameOnyx Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799
Party NameOnyx Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Monday, May 22, 2017ABANDONMENT NOTICE MAILED - INCOMPLETE RESPONSE
Monday, May 22, 2017ABANDONMENT - INCOMPLETE RESPONSE
Monday, May 1, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 1, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 25, 2017TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, October 25, 2016NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, October 25, 2016FINAL REFUSAL E-MAILED
Tuesday, October 25, 2016SU - FINAL REFUSAL - WRITTEN
Monday, October 10, 2016APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 10, 2016TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, October 6, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 6, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 3, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 28, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 28, 2016NON-FINAL ACTION E-MAILED
Wednesday, September 28, 2016SU - NON-FINAL ACTION - WRITTEN
Saturday, September 10, 2016STATEMENT OF USE PROCESSING COMPLETE
Thursday, August 25, 2016USE AMENDMENT FILED
Thursday, August 25, 2016TEAS STATEMENT OF USE RECEIVED
Wednesday, March 16, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 15, 2016EXTENSION 5 GRANTED
Monday, February 29, 2016EXTENSION 5 FILED
Monday, February 29, 2016TEAS EXTENSION RECEIVED
Saturday, August 29, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 27, 2015EXTENSION 4 GRANTED
Thursday, August 27, 2015EXTENSION 4 FILED
Thursday, August 27, 2015TEAS EXTENSION RECEIVED
Saturday, March 14, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 13, 2015EXTENSION 3 GRANTED
Tuesday, February 24, 2015EXTENSION 3 FILED
Tuesday, February 24, 2015TEAS EXTENSION RECEIVED
Wednesday, September 17, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 16, 2014EXTENSION 2 GRANTED
Tuesday, August 26, 2014EXTENSION 2 FILED
Wednesday, September 10, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 26, 2014TEAS EXTENSION RECEIVED
Saturday, March 1, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 27, 2014EXTENSION 1 GRANTED
Thursday, February 27, 2014EXTENSION 1 FILED
Thursday, February 27, 2014TEAS EXTENSION RECEIVED
Thursday, February 20, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 20, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 6, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 27, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 2, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 2, 2013PUBLISHED FOR OPPOSITION
Wednesday, June 12, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 30, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, May 21, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 20, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 20, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 14, 2013ASSIGNED TO LIE
Sunday, May 12, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 12, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 12, 2012NON-FINAL ACTION E-MAILED
Monday, November 12, 2012NON-FINAL ACTION WRITTEN
Sunday, November 4, 2012ASSIGNED TO EXAMINER
Friday, July 20, 2012NOTICE OF DESIGN SEARCH CODE MAILED
Thursday, July 19, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, July 16, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

kyprolis hematological tumors solid diseases disorders growths oncology pharmaceuticals prevention treatment